COVID-19 Vaccine

Washington University and Saint Louis University are participating in trials as a part of the COVID-19 Prevention Network (CoVPN), a newly organized network formed by the National Institute of Allergy and Infectious Diseases (NIAID) to develop and test vaccines and treatments in the fight against COVID-19.

The COVID-19 Prevention Network will participate in large-scale FDA phase 3 vaccine trials that will enroll thousands of participants from across the U.S. or in some cases around the world to determine whether the vaccines can prevent COVID-19 disease.

For more information about vaccine trials at Washington University School of Medicine, please email; or call 314-454-0058.